Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration

Clinical Nephrology

Volumn 65, Issue 1, 2006, Pages 34-42

  Palsson, R ^a   Laliberte, K A ^b   Niles, J L ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anticoagulation; Citrate; Continuous renal replacement therapy (CRRT); Continuous venovenous hemofiltration (CVVH); Replacement fluid

Indexed keywords

ANTICOAGULANT AGENT; BICARBONATE; CITRIC ACID; HEPARIN; LACTIC ACID;

ADULT; AGED; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; FEMALE; FLUID THERAPY; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FAILURE; MALE; METABOLIC ACIDOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT INDICATION; VASCULAR ACCESS; VASCULAR PATENCY;

EID: 30744475940     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65034     Document Type: Article

References (24)

1. Abramson S, Niles J 1999 Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8: 701-707
2. Bunchman T, Maxvold N, Barnett J, Hutchings A, Benfield M 2002 Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17: 150-154
3. Chong B, Jacques T 1991 Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia. Intens Care Med 17: 437
4. Cointault O, Kamar N, Bories P, Lavoyssiere L, Angles O, Rostaing L, Genestal M, Durand D 2004 Regional citrate anticoagulation in continuous venovenous hemodiafiltration using commercial solutions. Nephrol Dial Transplant 19: 171-178
5. Davenport A, Will EJ, Davison AM 1991 Hyperlactataemia and metabolic acidosis during haemofiltration using lactate-buffered fluids. Nephron 59: 461-465
6. Davenport A 2001 Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy. Contrib Nephrol 132: 313-322
7. Dorval M, Madore F, Courteau S, Leblanc M 2003 A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intens Care Med 29: 1186-1189
8. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C 2002 Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intens Care Med 28: 1419-1425
9. Gupta M, Wadhwa NK, Bukovsky R 2004 Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis 43: 67-73
10. Hofmann RM, Maloney C, Ward DM, Becker BN 2002 A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 24: 325-335
11. Kaplan A, Longnecker R, Folkert V 1984 Continuous arteriovenous hemofiltration: a report of six months experience. Ann Int Med 100: 358-367
12. Kutsogiannis D, Mayers I, Chin D, Gibney R 2001 Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35: 802-811
13. Mehta R, McDonald B, Aguilar M, Ward D 1990 Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976-981
14. Mehta R, McDonald B, Gabbai F, Pahl M, Pascual M, Farkas A, Kaplan R 2001 A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154-1163
15. Meier-Kriesche H, Gitomer J, Finkel K, DuBose T 2001 Increased total to ionized calcium ratio during continuous vonovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29: 748-752
16. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P 2004 Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intens Care Med 30: 260-265
17. Owen W, Lew N, Liu Y, Lowrie E, Lazarus J 1993 The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006
18. Palsson R, Niles J 1999 Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55: 1991-1997
19. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G 2000 Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26-30
20. Samuelsson O, Amiral J, Attman P, Bennegard K, Bjorck S, Larsson G, Tengborn L 1995 Heparin-induced thrombocytopenia during continuous haemofiltration. Nephrol Dial Transpl 10: 1768-1771
21. Schiffl H, Lang S, Fischer R 2002 Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305-310
22. Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M 2003 A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 18: 121-129
23. Tolwani A, Campbell R, Schenk M, Allon M, Warnock D 2001 Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60: 370-374
24. Ward D, Mehta R 1993 Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 43 (Suppl 41): S237-S244